Alessandro Guasconi
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.
Journal: Pulmonary pharmacology & therapeutics
Published: November 17, 2023
The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN).
Journal: Respiratory research
Published: September 06, 2023
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.
Journal: Respiratory research
Published: January 26, 2021
Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial.
Journal: International journal of chronic obstructive pulmonary disease
Published: November 11, 2020
Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 16, 2020
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation.
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation.
Journal: The European respiratory journal
Published: January 24, 2019
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.
Journal: International journal of chronic obstructive pulmonary disease
Published: November 23, 2018
Inhaled corticosteroid containing combinations and mortality in COPD.
Journal: The European respiratory journal
Published: July 02, 2018
Inhaled triple therapy in chronic obstructive pulmonary disease - Authors' reply.
Journal: Lancet (London, England)
Published: June 21, 2018
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Journal: Lancet (London, England)
Published: January 11, 2018
Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.
Journal: American journal of respiratory and critical care medicine
Published: June 09, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026